NASDAQ:GILD
Gilead Stock News
$67.03
+0.0800 (+0.119%)
At Close: Apr 23, 2024
Gilead Sciences to Present at Upcoming Investor Conference
04:05pm, Thursday, 21'st Dec 2023
FOSTER CITY, Calif.--(BUSINESS WIRE)-- #Biotech--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conference: J.P. Morgan Healthcare
3 Biotech Stocks to Buy in the TradeSmith ‘Green Zone'
11:23am, Thursday, 21'st Dec 2023
Investors in search of high-risk, high-reward investments can often find them among the top biotech stocks to buy. Identifying worthwhile opportunities can be easier said than done when investing in b
Gilead (GILD), Compugen Collaborate for Immunotherapy Program
12:01pm, Wednesday, 20'th Dec 2023
Gilead (GILD) enters into a license agreement with Compugen for its pre-clinical immunotherapy program.
Gilead Sciences and Compugen strike commercialization deal for immunotherapy program
11:31am, Wednesday, 20'th Dec 2023
Gilead Sciences, Inc. (NASDAQ:GILD) announced that it has entered into an agreement with Compugen Ltd (NASDAQ:CGEN) to exclusively license Compugen's pre-clinical antibody program against IL-18 bindi
Compugen stock rockets on anti-tumor drug deal with Gilead
07:13am, Tuesday, 19'th Dec 2023
Compugen Ltd.'s stock CGEN, -3.36% was up by 113% in premarket trading on Tuesday after the company said it agreed to sell exclusive rights to Gilead Sciences Inc. GILD, -1.03% for later stage develop
Gilead (GILD) Outperforms Industry in 6 Months: What Lies Ahead?
02:17pm, Friday, 15'th Dec 2023
Gilead (GILD) gains 3.7% in six months as its oncology portfolio gains traction and its HIV business maintains momentum.
Gilead Sciences (GILD) Stock Sinks As Market Gains: Here's Why
07:32pm, Thursday, 14'th Dec 2023
In the closing of the recent trading day, Gilead Sciences (GILD) stood at $81.78, denoting a -1.58% change from the preceding trading day.
A Bull Market Is Coming: 1 Stock That Could Rocket 219% Higher in 2024, According to Wall Street
05:29am, Tuesday, 12'th Dec 2023
Wall Street analysts following Iovance Biotherapeutics set price targets that suggest the stock can triple your money in 2024. Iovance Biotherapeutics is developing cell-based cancer therapies, and th
6 Health Care Dividend Stocks To By Hand Over Fist
10:48am, Monday, 11'th Dec 2023
This biotech giant remains a top stock for investors to buy and pays a solid 3.13% dividend.
This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks
01:48pm, Sunday, 10'th Dec 2023
Chimeric antigen receptor T-cell medicines could have more risks than previously known. Novartis' drug Kymriah is going to be under the most scrutiny for now.
Dividend Lovers Betting Big on 6 Goldman Sachs Top Conviction List Picks for 2024
09:12am, Saturday, 09'th Dec 2023
This integrated giant is safer for investors looking to get positioned in the energy sector, has backed up some, and now yields a strong 4.17% dividend.
12 Companies That Had IPOs in 1992: Best and Worst Performers
08:48am, Saturday, 09'th Dec 2023
In 1992, about 412 companies had an initial public offering (IPO) in the United States.
3 biotech powerhouses poised to thrive amid sector rebound
10:11am, Friday, 08'th Dec 2023
The biotech sector and its popular ETF, the iShares Biotechnology ETF NASDAQ: IBB, has lagged the overall market during the year. However, in recent weeks, the sector has enjoyed a significant rally a
5 Dividend Growth Stocks To Consider Buying
02:25pm, Thursday, 07'th Dec 2023
Korn Ferry, Gilead Sciences, Qualcomm, Ralph Lauren, and Manpower are identified as five companies with high dividend yields and strong capacity for future dividend increases. Korn Ferry is a leader i
Why Is Gilead (GILD) Up 1.9% Since Last Earnings Report?
12:48pm, Thursday, 07'th Dec 2023
Gilead (GILD) reported earnings 30 days ago. What's next for the stock?
